Description
PaliperidoneisanantipsychoticcompoundthatinhibitsD2receptorsand5-HT2Areceptorsandisusedtotreatschizophrenia.Paliperidonealsoattenuatesepinephrine-andSEROtonin-inducedplateletaggregation.
PaliperidoneisanantipsychoticcompoundthatinhibitsD2receptorsand5-HT2Areceptorsandisusedtotreatschizophrenia.Paliperidonealsoattenuatesepinephrine-andSEROtonin-inducedplateletaggregation.
CasNo. | 144598-75-4 |
---|---|
Purity | ≥97% |
Formula | C23H27FN4O3 |
FormulaWt. | 426.48 |
IUPACName | 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one |
Synonym | 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one;9-OH-risperidone |
MeltingPoint | 158-160°C |
Solubility | DMSO:>5mg/mL |
Appearance | Anoffwhiteorpaleyellowpowder |
StoreTemp | Ambient |
---|---|
ShipTemp | Ambient |
InfoSheet | P0144InfoSheetPDF |
---|
KozielskaM,JohnsonM,PillaReddyV,etal.Pharmacokinetic-pharmacodynamicmodelingoftheD2and5-HT(2A)receptoroccupancyofrisperidoneandpaliperidoneinrats.PharmRes.2012Jul;29(7):1932-48.PMID:22437487.
GildayE,NasrallahHA.Clinicalpharmacologyofpaliperidonepalmitateaparenterallong-actingformulationforthetreatmentofschizophrenia.RevRecentClinTrials.2012Feb;7(1):2-9.PMID:22023179.
DeClerckF,SomersY,MannaertE,etal.Invitroeffectsofrisperidoneand9-hydroxy-risperidoneonhumanplateletfunction,plasmacoagulation,andfibrinolysis.ClinTher.2004Aug;26(8):1261-73.PMID:15476907.